HRT and Dementia Risk: New Research Finds No Meaningful Link
Table of Contents
There is “no evidence” that hormone therapy (HT), also known as hormone replacement therapy (HRT), increases or decreases the risk of dementia in women, according to a recent study. The findings reinforce current clinical guidance and suggest that HT does not considerably impact cognitive decline.
Study Details & Findings
A study conducted by University College London, with support from the University of Exeter, investigated the relationship between hormone therapy and the risk of mild cognitive impairment (MCI). The research, published in December 2023 and part of a larger review commissioned by the World Health Organisation, analyzed data to determine if HRT had any notable effect on cognitive function.
The study found “no significant association” between HRT and the development of MCI, a condition characterized by problems with memory or thinking that can sometimes progress to dementia. Details of the study can be found on the University of Exeter news page here.
Understanding mild cognitive Impairment (MCI) and Dementia
It’s vital to understand the difference between MCI and dementia.
* Mild Cognitive Impairment (MCI): MCI causes noticeable cognitive changes, such as memory loss or difficulty with language, that are greater than expected for a person’s age. However, individuals with MCI can still function independently in daily life. More information about MCI can be found on the Alzheimer’s Society website: https://www.alzheimers.org.uk/about-dementia/types-dementia/mild-cognitive-impairment-mci.
* Dementia: Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. It is caused by damage to brain cells and can affect memory, thinking, behavior, and the ability to perform everyday tasks.
While MCI can sometimes be a precursor to dementia, it does not always develop into the condition.
Implications and Future Research
Experts emphasize that while this study provides valuable insight, further research is still needed. The current findings “reinforce current clinical guidance,” suggesting that decisions regarding HRT should be made on a case-by-case basis, considering individual health needs and risks, rather than concerns about dementia risk.
The National Institute on Aging provides extensive information on dementia and related research: https://www.nia.nih.gov/. Ongoing studies will continue to explore the complex relationship between hormonal changes, cognitive health, and the potential benefits and risks of hormone therapy.
Keep reading
- Chuseok Health Check: Spotting Knee Arthritis in Parents
- How Interferon-Alpha Treats Rare Blood Cancers: New Study Reveals Mechanism
- Breakthrough Salk Study Uncovers Mechanism Behind Immunotherapy Resistance: Interferons, Mitochondrial Dysfunction, and PGE2″ Interferons, mitochondrial dysfunction and PGE2: Salk study reveals mechanism behind immunotherapy resistance. Boost its search engine visibility with relevant keywords for maximum impact. Immunotherapy resistance remains one of the biggest hurdles in cancer treatment. According to a recent study published in the journal Nature Communications, scientists at the Salk Institute have made a groundbreaking discovery that sheds light on the underlying mechanisms behind this resistance. The study reveals that interferons, a type of protein that plays a crucial role in the immune system, can contribute to mitochondrial dysfunction in cancer cells. This dysfunction can lead to the production of prostaglandin E2 (PGE2), a molecule that promotes tumor growth and resistance to immunotherapy. In their study, the researchers found that PGE2 production was a key factor in the development of immunotherapy resistance in cancer cells. The team used a combination of experimental and computational models to investigate the relationship between interferons, mitochondrial dysfunction, and PGE2 production. The findings of the study suggest that targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance. The researchers propose that blocking PGE2 receptors or inhibiting its production could help restore the function of mitochondria in cancer cells, making them more susceptible to immunotherapy. The study’s authors hope that their findings will pave the way for the development of new therapies that can overcome immunotherapy resistance and improve treatment outcomes for cancer patients. Key Takeaways: – Interferons contribute to mitochondrial dysfunction in cancer cells – Mitochondrial dysfunction leads to PGE2 production, promoting tumor growth and resistance to immunotherapy – Targeting PGE2 production could be a potential strategy for overcoming immunotherapy resistance – Restoring mitochondrial function in cancer cells could make them more susceptible to immunotherapy Keywords: immunotherapy resistance, interferons, mitochondrial dysfunction, PGE2, Salk Institute, cancer treatment, breakthrough study, Nature Communications. (archyworldys.com)